https://www.selleckchem.com/pr....oducts/ly2157299.htm
inflammatory activity (IA) is a cause of hypoalbuminemia in patients with acute heart failure (AHF). the main objective of this study was to evaluate whether an AI modulator treatment contributes to correcting albuminemia in this context. in this clinical trial 43 patients with AHF, hypoalbuminemia (serum albumin 3.4 g/dl), and elevated IA [C-reactive protein (CRP) 25 mg/l] were randomly assigned to receive omega-3 fatty acids (4 g daily) or placebo for 4 weeks. Albuminemia and CRP were reassessed at weeks 1 and 4. An analysis of
Like
Comment
Share
